ISMP is extending the deadline date for healthcare facilities to submit their findings for its new self assessment on high-alert medications from December 15, 2017 to February 28, 2018. Each section of the ISMP Medication Safety Self Assessment for High-Alert Medications can be completed and submitted to ISMP separately when ready. ISMP is extending the deadline to ensure that organizations have enough time to participate in the full assessment by evaluating all the categories of high-alert medications used in their facilities. To access the self assessment workbook, go to: www.ismp.org/selfassessments/SAHAM/Default.aspx
ISMP is holding a webinar entitled “Identifying Risk in Your Organization: Does Error Reporting Capture Everything?” on Thursday, November 9, 2017 from 1:30-3:00pm EST. The program is approved for 1.5 contact hours (0.15 CEUs) of ACPE credit. For more information and to register, go to: http://www.proce.com/ISMPNovember2017
MSOS is adding a “Quick Survey” feature to our website next month. Members will be asked one new question of interest each month on the MSOS website, that will offer 3 to 5 multiple choice options. Participants will receive instant feedback of the survey results. We are reaching out to MSOS members to ask for ideas/topics for the one question surveys that would be of interest to them. Please submit your ideas as a multiple choice question with answers to email@example.com. Members will receive an announcement with each new survey that is posted to the website.
Please note: If you add an attachment to any Forum post, it will not be viewable in the email that is sent to all members. The attachment is only viewable in the Forum section of the MSOS website (www.medsafetyoffice.org).This is due to the functionality of the software we utilize. Please take this into consideration when writing and viewing posts. Thanks.
ISMP has introduced a new tool to help hospitals, long-term care facilities, and certain outpatient facilities evaluate their best practices related to high-alert medications, identify opportunities for improvement, and track their experiences over time. The ISMP Medication Safety Self Assessment® for High-Alert Medications focuses on general high-alert medications and 11 specific medication categories--including opioids, insulin, neuromuscular blocking agents, chemotherapy, and moderate and minimal sedation. Participants who submit assessment findings to ISMP anonymously via a secure internet portal by December 15, 2017 will be able to obtain their weighted scores so they can compare themselves to demographically similar organizations. Participation also can help organizations meet requirements for managing high-alert medications from regulatory and accrediting agencies, such as the Centers for Medicare & Medicaid Services and The Joint Commission. To access the self assessment workbook, go to: http://www.ismp.org/selfassessments/SAHAM.